Skip to main content Accessibility help
×
Home

Do children requiring long-term warfarin therapy present a bleeding risk during routine immunisation?

  • Emma K. Thursky (a1), Anna N. Eason (a1), Emily I. Blake (a1), Emily M. Kitson (a1), Cassandra Choy (a1), Hollie S. Nosworthy (a1), Sonja Elia (a2), Fiona Newall (a3) and Sophie Jones (a3)...
  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Do children requiring long-term warfarin therapy present a bleeding risk during routine immunisation?
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Do children requiring long-term warfarin therapy present a bleeding risk during routine immunisation?
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Do children requiring long-term warfarin therapy present a bleeding risk during routine immunisation?
      Available formats
      ×

Abstract

Copyright

Corresponding author

Correspondence to: F. Newall, Clinical Haematology, The Royal Children’s Hospital, 50 Flemington Road, Parkville, Victoria 3052, Australia. Tel: +619345 5762; Fax: +61 3 9347 1819; E-mail: fiona.newall@rch.org.au

References

Hide All
1. Monagle, P, Chan, AK, Goldenberg, NA, et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: 737801.
2. Monagle, P, Newall, F. Anticoagulation in children. Thromb Res 2012; 130: 142146.
3. Newall, F, Savola, H, Campbell, J, Monagle, P. Anticoagulation clinics for children achieve improved warfarin management. Thromb Res 2004; 114: 59.
4. Streif, W, Andrew, M, Marzinotto, V, Chan, AK, Julian, JA, Mitchell, L. Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients. Blood 1999; 94: 30073014.
5. Wong, SC, Batchelor, K, Bua, J, Newall, F. Safety and efficacy of warfarin in paediatric patients with prosthetic cardiac valves: a retrospective audit. Thromb Res 2011; 128: 331334.
6. National Health and Medical Research Council. The Australian Immunisation Handbook, 10th edn. National Capital Press, Canberra, 2013, Retrieved May 17, 2014, from http://www.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook10-home.

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed